Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenshun Cheng

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Briefings in Bioinformatics|June 8, 2025
Systematic identification of cancer-type-specific drugs based on essential genes and validations in lung adenocarcinomaXiang Lian, Xia Kuang, Dong-Dong Zhang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 2, 2022
Risk factors for polymyxin B-associated acute kidney injuryKang Chang, Haibo Wang, Jianping Zhao, et al.
Journal of Clinical Laboratory Analysis|May 10, 2021
Targeted resequencing showing novel common and rare genetic variants increases the risk of asthma in the Chinese Han populationJuan Liu, Yanhan Deng, Bo Yu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2020
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, ChinaPingzheng Mo, Yuanyuan Xing, Yu Xiao, et al.
Chest|May 16, 2026
Anti-C5a antibody STSA-1002 for patients with acute respiratory distress syndrome due to viral pneumonia: a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trialYeming Wang, Xiaobo Huang, Zhenshun Cheng, et al.
Frontiers in Medicine|June 27, 2022
Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i> or Carbapenem-Resistant <i>Acinetobacter baumannii</i>Kang Chang, Haibo Wang, Jianping Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 18, 2016
Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage ProductionYingying Yao, Yi Wang, Zhijun Zhang, et al.
Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|October 19, 2024
Tele-rehabilitation in COVID-19 survivors (TERCOV): An investigator-initiated, prospective, multi-center, real-world studyGeyi Wen, Lulu Yang, Shiwei Qumu, et al.
Journal of Clinical Laboratory Analysis|May 4, 2021
A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 (HYAL1) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han ChineseJuan Liu, Yanhan Deng, Zheng Wang, et al.
Trials|May 26, 2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trialYeming Wang, Fei Zhou, Dingyu Zhang, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Briefings in Bioinformatics|June 8, 2025
Systematic identification of cancer-type-specific drugs based on essential genes and validations in lung adenocarcinomaXiang Lian, Xia Kuang, Dong-Dong Zhang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 2, 2022
Risk factors for polymyxin B-associated acute kidney injuryKang Chang, Haibo Wang, Jianping Zhao, et al.
Journal of Clinical Laboratory Analysis|May 10, 2021
Targeted resequencing showing novel common and rare genetic variants increases the risk of asthma in the Chinese Han populationJuan Liu, Yanhan Deng, Bo Yu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2020
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, ChinaPingzheng Mo, Yuanyuan Xing, Yu Xiao, et al.
Chest|May 16, 2026
Anti-C5a antibody STSA-1002 for patients with acute respiratory distress syndrome due to viral pneumonia: a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trialYeming Wang, Xiaobo Huang, Zhenshun Cheng, et al.
Frontiers in Medicine|June 27, 2022
Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i> or Carbapenem-Resistant <i>Acinetobacter baumannii</i>Kang Chang, Haibo Wang, Jianping Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 18, 2016
Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage ProductionYingying Yao, Yi Wang, Zhijun Zhang, et al.
Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|October 19, 2024
Tele-rehabilitation in COVID-19 survivors (TERCOV): An investigator-initiated, prospective, multi-center, real-world studyGeyi Wen, Lulu Yang, Shiwei Qumu, et al.
Journal of Clinical Laboratory Analysis|May 4, 2021
A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 (HYAL1) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han ChineseJuan Liu, Yanhan Deng, Zheng Wang, et al.
Trials|May 26, 2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trialYeming Wang, Fei Zhou, Dingyu Zhang, et al.
Pageof 7